These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 945687

  • 1. Plasma heparin neutralizing activity. Its use in the evaluation of thrombocytopenia and thrombocytosis.
    Dana B, Carvalho AC, Ellman L.
    Am J Clin Pathol; 1976 Jun; 65(6):964-9. PubMed ID: 945687
    [Abstract] [Full Text] [Related]

  • 2. A rapid method for assessing megathrombocytes: its application to thrombocytotic and acquired thrombocytopenic states.
    Hunt FA.
    Pathology; 1976 Jan; 8(1):47-55. PubMed ID: 987570
    [Abstract] [Full Text] [Related]

  • 3. [Clinical studies and detecting method (R.I.A.) of platelet factor 4 level in thrombocytopenia, thrombocytosis and thrombosis (author's transl)].
    Mizuno T, Taketomi Y, Fujimura K, Kuramoto J.
    Horumon To Rinsho; 1980 Feb; 28(2):207-12. PubMed ID: 7379324
    [No Abstract] [Full Text] [Related]

  • 4. Diagnosis of microthrombocytosis and immune-mediated thrombocytopenia in dogs with thrombocytopenia: 68 cases (1987-1989).
    Northern J, Tvedten HW.
    J Am Vet Med Assoc; 1992 Feb 01; 200(3):368-72. PubMed ID: 1548175
    [Abstract] [Full Text] [Related]

  • 5. [Thrombocytopenia].
    Gadó K, Domján G.
    Orv Hetil; 2014 Feb 23; 155(8):291-303. PubMed ID: 24534877
    [Abstract] [Full Text] [Related]

  • 6. Subcellular localization of the heparin-neutralizing factor in blood platelets.
    Da Prada M, Jakábová M, Lüscher EF, Pletscher A, Richards JG.
    J Physiol; 1976 May 23; 257(2):495-502. PubMed ID: 950602
    [Abstract] [Full Text] [Related]

  • 7. Platelet consumption and plasma concentration of platelet factor 4 (PF-J).
    Gjesdal K, Abrahamsen AF.
    Scand J Haematol; 1976 Jul 23; 17(1):5-9. PubMed ID: 959773
    [Abstract] [Full Text] [Related]

  • 8. [Determination of platelest factor III. (Total content and availability)].
    Scrobohaci ML.
    Med Interna (Bucur); 1974 May 23; 26(5):623-32. PubMed ID: 4526294
    [No Abstract] [Full Text] [Related]

  • 9. [Significance of the inhibitors in disseminated intravascular coagulation syndrome and relationship among antithrombin III, platelet factor 4 and heparin (author's transl)].
    Sakuragawa N, Takahashi K, Hoshiyama M, Matsuoka M.
    Nihon Ketsueki Gakkai Zasshi; 1977 Apr 23; 40(2):218-26. PubMed ID: 578067
    [No Abstract] [Full Text] [Related]

  • 10. Distribution of fibrinogen, and platelet factors 4 and XIII in subcellular fractions of human platelets.
    Broekman MJ, Handin RI, Cohen P.
    Br J Haematol; 1975 Sep 23; 31(1):51-5. PubMed ID: 1212435
    [Abstract] [Full Text] [Related]

  • 11. Altered platelet phospholipid-dependent thrombin generation in thrombocytopenia and thrombocytosis.
    Lee LH, Baglin T.
    Br J Haematol; 1995 Jan 23; 89(1):131-6. PubMed ID: 7833251
    [Abstract] [Full Text] [Related]

  • 12. Dynamic coagulation studies: influence of normal and abnormal platelets on clot structure formation.
    Glover CJ, McIntire LV, Brown CH, Natelson EA.
    Thromb Res; 1975 Jul 23; 7(1):185-98. PubMed ID: 1154337
    [No Abstract] [Full Text] [Related]

  • 13. Soluble platelet glycoprotein V in distinct disease states of pathological thrombopoiesis.
    Acar K, Aksu S, Beyazit Y, Haznedaroglu IC, Koca E, Cetiner D, Sayinalp N, Buyukasik Y, Goker H, Kirazli S, Ozcebe OI.
    J Natl Med Assoc; 2008 Jan 23; 100(1):86-90. PubMed ID: 18277814
    [Abstract] [Full Text] [Related]

  • 14. Platelet factor-4 excretion in myeloproliferative disease: implications for the aetiology of myelofibrosis.
    Burstein SA, Malpass TW, Yee E, Kadin M, Brigden M, Adamson JW, Harker LA.
    Br J Haematol; 1984 Jul 23; 57(3):383-92. PubMed ID: 6743563
    [Abstract] [Full Text] [Related]

  • 15. [Severe thrombopenias during heparin therapy. A phenomenon of intra-vascular platelet aggregation].
    Faivre R, Kieffer Y, Bassand JP, Maurat JP.
    Arch Mal Coeur Vaiss; 1983 Oct 23; 76(10):1178-86. PubMed ID: 6418095
    [Abstract] [Full Text] [Related]

  • 16. Platelet disorders: an overview.
    Krishnegowda M, Rajashekaraiah V.
    Blood Coagul Fibrinolysis; 2015 Jul 23; 26(5):479-91. PubMed ID: 26126029
    [Abstract] [Full Text] [Related]

  • 17. A simplified assay method for platelet factor 4 in plasma and in platelets with a chromogenic substrate.
    Vinazzer H.
    Haemostasis; 1978 Jul 23; 7(6):352-8. PubMed ID: 720957
    [Abstract] [Full Text] [Related]

  • 18. Heparin-induced thrombocytopenia in essential thrombocytosis.
    Murawaki A, Nakayasu H, Doi M, Suzuki-Kinoshita K, Asai Y, Omura H, Nakashima K.
    J Stroke Cerebrovasc Dis; 2012 Nov 23; 21(8):916.e1-5. PubMed ID: 22425438
    [Abstract] [Full Text] [Related]

  • 19. Use of the megathrombocyte as an index of megakaryocyte number.
    Garg SK, Amorosi EL, Karpatkin S.
    N Engl J Med; 1971 Jan 07; 284(1):11-7. PubMed ID: 5099586
    [No Abstract] [Full Text] [Related]

  • 20. Clinical usefulness of testing for a heparin-dependent platelet-aggregating factor in patients with suspected heparin-associated thrombocytopenia.
    Kelton JG, Sheridan D, Brain H, Powers PJ, Turpie AG, Carter CJ.
    J Lab Clin Med; 1984 Apr 07; 103(4):606-12. PubMed ID: 6699475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.